| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() Nutropin Depot (Somatropin (rDNA)) Growth Hormone Available In The US SOUTH SAN FRANCISCO, CA and CAMBRIDGE, MA -- June 29, 2000 -- Genentech, Inc. and Alkermes, Inc. announced that Nutropin Depot™ (somatropin (rDNA) for injectable suspension) -- the first long-acting dosage form of recombinant human growth hormone -- is now being shipped to the pediatric endocrine community in the United States. Nutropin Depot was approved by the U.S. Food and Drug Administration (FDA) on December 23, 1999. Nutropin Depot is a long-acting form of Genentech's human growth hormone using Alkermes' ProLease® injectable extended-release drug delivery system. Alkermes performs the manufacturing operations that convert Genentech's Nutropin (somatropin (rDNA origin) for injection) bulk product into the long-acting dosage form. Genentech will market the product in the United States. Related Links: Genentech, Inc. and Alkermes, Inc.
|